Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy
Alimentary Pharmacology and Therapeutics Feb 17, 2018
Tada T, et al. - Changes in liver stiffness and steatosis were evaluated in patients with chronic hepatitis C virus (HCV) who received direct-acting anti-viral therapy and achieved sustained virological response (SVR). Among chronic HCV patients who received direct-acting anti-viral therapy, viral eradication reduced both liver stiffness and steatosis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
